Company intelligence / Profile preview

CryoLogyx

Coventry, England, United Kingdomcryologyx.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

CryoLogyx has developed proprietary cryopreservation solutions that enable the production of high-quality assay-ready cells. These products are designed to improve reproducibility and efficiency in drug discovery and cell therapy research by providing ready-to-use frozen cells with high post-thaw viability. The company’s technology has been validated through partnerships and early commercial adoption; however, as a tools/platform provider rather than a therapeutics developer, it does not have clinical results in the traditional sense.

Modalities: Cell therapy (enabling technology)Assay-ready cells (biological tools)
Industry: Non-Drug Biotech

Partnerships

CliniSciencesNORGANOID

Beyond the preview

Go deeper on CryoLogyx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CryoLogyx.

Explore the full profile